Objective-Periostin is a secreted protein that can alter extracellular matrix remodeling in response to tissue injury. However, the functional role of periostin in the development of atherosclerotic plaques has yet to be described despite its observed induction in diseased vessels and presence in the serum. Approach and Results-Hyperlipidemic, apolipoprotein E-null mice (ApoE 
C ardiovascular disease remains the leading cause of mortality in the Western world accounting for one third of all deaths, primarily caused by myocardial infarction as a direct result of atherosclerosis. 1 Therefore, understanding the biological mechanisms underlying atherosclerotic plaque development is critical toward uncovering new treatment strategies to prevent or delay this disease. Extensive research during the past few decades has shown that imbalances in vascular smooth muscle cell (VSMC) activation, excess extracellular matrix (ECM) production, persistent inflammation, and retention of cholesterol-rich debris can all contribute to plaque formation in atherosclerosis. 2, 3 VSMCs are a critical cell type in the vessel wall, which are usually quiescent in stable vessels. However, on injury, VSMCs switch from a contractile, quiescent phenotype to a synthetic, proliferative phenotype, where they produce ECM proteins, such as periostin, thereby contributing to the deposition of a complex and mature cross-linked collagen matrix. 2, 4, 5 Transforming growth factor-β (TGF-β) signaling stimulates VSMCs to proliferate and migrate forming the fibrous cap of the plaque. [6] [7] [8] Matrix metalloproteinases (MMPs) are also expressed to facilitate VSMC migration through the plaque via ECM degradation. Interestingly, several lines of evidence suggest both proatherogenic and antiatherogenic roles for many ECM proteins. 6, [9] [10] [11] [12] However, both clinical and experimental data agree that excessive MMP expression can contribute to plaque destabilization by favoring ECM degradation, ultimately predisposing plaques to rupture. 13, 14 Periostin is a 90-kDa secreted ECM/matricellular protein that contains 4 fasciclin domains homologous to the insect protein fasciclin I, which is involved in cell adhesion. 15, 16 Periostin has been proposed to function upstream and downstream of TGF-β. 15, 16 At baseline, low levels of periostin are detected in various adult tissues, but with acute injury periostin expression and secretion are dramatically increased. 5, 17 For example, periostin is abundantly re-expressed in the heart after both myocardial infarction and pressure overload injuries. [18] [19] [20] In addition, periostin is expressed in embryonic cardiac valves, is re-expressed with valvular injury in the adult, and is known to be secreted by VSMCs. 17, 21, 22 Studies have shown that periostin is abundant in degenerated human cardiac valves and the absence of periostin in mice is able to rescue valve degeneration. 17 In the vasculature, periostin is upregulated in vessel walls of rat carotid arteries after balloon injury, and it has been detected within the intimal portion of human vessels containing atherosclerotic plaques. 22, 23 In addition, recent work has shown that periostin can act as a chemoattractant for tumor-associated macrophage recruitment in a mouse model of glioblastoma. 24 One of the hallmarks of atherosclerotic plaque progression is the migration of monocytes through the vessel wall where these cells differentiate into macrophages and consume excess lipids to form foam cells. Foam cells make up the lipid core, and death of these cells eventually results in the development of the necrotic core. 25, 26 A role for periostin in the regulation of ECM production and maturation has been defined in many tissues, including the heart and skin, where the loss of periostin results in decreased collagen cross linking and degradation of the ECM. 4, 5, 18 Periostin is also known to bind to collagen I in the heart, and the loss of periostin results in decreased collagen V deposition after MI with altered ventricular remodeling. 4, 5, 18 Although periostin has been linked to the pathogenesis of many cardiovascular diseases, its specific role during atherosclerotic plaque formation and progression remains undefined.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Periostin Is Induced in Atherosclerotic Plaques
To determine whether periostin is upregulated during the development of atherosclerosis, ApoE −/− mice were fed a western, high-fat diet (HFD) and their aortas and serum were assayed for periostin. Indeed, periostin protein was significantly increased in the aortic intima and plaques of ApoE −/− mice after 14 weeks on HFD ( Figure 1A) . As a control, we also assessed the aortic valves, which are known areas of continuous periostin expression. 21, 27, 28 Serum levels of periostin were also increased in ApoE −/− mice compared with controls after 6 weeks of HFD ( Figure 1B Figure 3A , arrows). We quantified the percent of the total plaque occupied by fibrous cap, which was significantly smaller in ApoE −/− Postn −/− mice compared with that in ApoE −/− controls ( Figure 3B ). In addition, the plaques within ApoE −/− mice had more cholesterol clefts when compared with the plaques within ApoE −/− Postn −/− mice ( Figure 3C ). Together, these data suggest that periostin contributes to plaque development and that the loss of this gene seems to delay disease progression.
Collagen Disorganization in
On the basis of previous findings that the loss of periostin alters the ECM in the heart, skin, and skeletal muscle after injury, we hypothesized that deletion of Postn would also affect the ECM in aortic vasculature, which could affect atherosclerosis susceptibility and progression. Sirius red staining showed no difference in total collagen content normalized to plaque area in histological sections of aortas from ApoE −/− and ApoE −/− Postn −/− HFD-fed mice ( Figure 4A and 4B). However, when visualized under polarized light to assess collagen fiber maturity, the plaque region of ApoE −/− mice contained significantly more orange-red, tightly packed, and well-organized collagen fibers, whereas ApoE −/− Postn −/− plaques displayed significantly greater yellow green, loosely packed, and less cross-linked collagen fibers ( Figure 4A and 4C we analyzed mRNA expression of several collagens, MMPs, and other ECM remodeling genes in thoracic aortas from all 4 groups of mice not subjected to HFD. It is important to note that even on normal diet, ApoE −/− mice develop hypercholesterolemia by 6 weeks of age, and early plaque development can be observed by 10 months of age. 29 Therefore, to exclude any potential alterations in mRNA expression because of the increased plaque burden in the ApoE −/− mice on HFD, these analyses were performed on mice fed normal chow. In addition, vessels early in disease might also suggest a more mechanistically proximal array of gene expression changes that contributes to disease initiation and progression. In early disease aortas, we observed that expression of collagens 1α1, 1α2, and 3α1 were all significantly increased in aortas from both Postn Several MMPs have been shown to be involved in atherosclerotic plaque development and maintenance. 30, 31 The expression (mRNA and protein) and enzymatic activity of MMP3 were significantly increased in ApoE −/− Postn −/− aortas compared with the 3 other groups ( Figure 4H -4J). MMP9 expression remained unchanged ( Figure 4K ). MMP12 has been shown to correlate with advanced atherosclerotic lesions in humans and promote macrophage invasion. 30 We found decreased mRNA levels of MMP12 in ApoE −/− Postn −/− versus ApoE −/− aortas, suggesting reduced disease propensity ( Figure 4L ). In addition, we found significantly increased expression of procollagen-lysine, 2-oxoglutarate 5-dioxygenase-1 and MMP13, genes that are involved in collagen degradation and maturation, in prediseased ApoE −/− Postn −/− aortas compared with ApoE −/− aortas ( Figure 4M and 4N). 31, 32 We also observed a significant increase in lysyl oxidase expression, which is required for plaque stability and collagen cross linking in atherosclerosis, in early diseased
aortas ( Figure 4O ). These data suggest that the loss of Postn in the ApoE −/− background does not impair collagen production but that it likely affects collagen organization or maturation because of decreased cross linking and MMP-mediated degradation, which could affect the initiation and progression of atherosclerosis. Taken together, the loss of the Postn gene seems to lead to select defects in vascular collagen homeostasis early in disease, which alters atherosclerotic progression in ApoE −/− mice. . 
Atherosclerotic Plaques
Inflammatory events in the vessels typically lead to VSMC phenotype changes, which we analyzed here. A significant decrease was observed in the number of α-smooth muscle actin (α-SMA) positive cells, a marker of the contractile phenotype of VSMCs, in the aortas of ApoE −/− Postn −/− mice compared with ApoE −/− mice, suggesting a more synthetic phenotype ( Figure 5A ). We confirmed and expanded these results by performing quantitative polymerase chain reaction for gene expression changes that are associated with the synthetic phenotype of VSMCs on thoracic aortas before disease manifestation ( Figure 5B-5D ). We observed decreases in α-SMA and smooth muscle myosin heavy chain mRNA in ApoE −/− and ApoE −/− Postn −/− compared with WT, suggesting that VSMCs may switch phenotype early in disease progression ( Figure 5B and 5C). Unexpectedly, the loss of periostin protein alone resulted in a significant reduction in α-SMA and smooth muscle myosin heavy chain mRNA levels in prediseased aortas, which could be associated with an underlying defect in the ECM environment of these vessels ( Figure 5B and 5C). Osteopontin, a marker of the synthetic cellular phenotype, was also dramatically induced in ApoE −/− aortas at disease initiation, but this effect was significantly reduced in double null aortas suggesting a potential delay in disease progression ( Figure 5D ). To further investigate the synthetic VSMC phenotype, mice were injected with 5-ethynyl-2′-deoxyuridine (EdU) after both 6 and 14 weeks of HFD. ApoE −/− Postn −/− mice on diet for both time points had significantly more cellular proliferation in the aortas as measured by EdU-positive nuclei compared with ApoE −/− mice ( Figure 5E-5G ). In addition, the majority of the EdU-positive nuclei were also positive for vimentin staining, a marker of synthetic VSMCs ( Figure 5E ). 33, 34 Furthermore, quantitative polymerase chain reaction performed on isolated WT and Postn −/− VSMCs showed that the loss of periostin resulted in significantly decreased mRNA expression of neuropeptide Y, macrophage scavenger receptor 1, and β2 integrin ( Figure 5H-5J) . Several studies have shown these genes to be upregulated in the development of atherosclerosis. [35] [36] [37] Taken together, these data indicate that the VSMC phenotype switch characteristic of atherosclerosis is intact in ApoE −/− Postn −/− mice.
Loss of Periostin Affects the Infiltration of Inflammatory Cells Into the Plaque
Periostin is known to be involved in the inflammatory response; therefore, we surveyed the macrophage content of aortic plaques Figure 6A and 6B) . 17, 38 To understand the mechanism behind decreased macrophage content in ApoE −/− Postn −/− plaques, we analyzed isolated macrophages. Bone marrow-derived macrophages cultured for 5 days in media containing 100 U/mL of macrophage colony-stimulating factor were analyzed by flow cytometry and found to be 96% (WT) and 94% (Postn −/− ) CD11b positive, indicative of differentiated macrophages ( Figure  I in the online-only Data Supplement). A previous study showed that periostin can act as a chemoattractant for macrophages in a model of glioblastoma. 24 Indeed, similar to TGF-β, recombinant periostin protein caused a significant increase in the migration of WT macrophages but not Postn −/− macrophages ( Figure 6C ). We also investigated whether periostin produced and secreted by VSMCs could be responsible for macrophage recruitment to atherosclerotic plaques. However, we observed no difference in the ability of WT macrophages to migrate toward WT or Postn −/− VSMCs, either with or without costimulation from TGF-β, suggesting that factors other than periostin secreted from VSMCs were part of the migratory effect ( Figure 6D ). Macrophages deleted for Postn −/− were unable to migrate in response to TGF-β; yet they still responded to other general factors secreted from both WT and Postn −/− VSMCs ( Figure 6D ). These results show a fundamental defect in the ability of Postn −/− macrophages to migrate toward TGF-β. We observed no differences in the ability of WT or Postn Figure 6E ). This, in turn, results in a decrease in the number of macrophages available to differentiate into foam cells that will eventually form the lipid core, resulting in a smaller plaque ( Figure 6F) . 
Discussion
The data presented here provide the first genetic evidence supporting the role of periostin in the pathogenesis of atherosclerosis. We observed a decrease in plaque size and overall plaque burden in the ApoE −/− Postn −/− mice compared with ApoE −/− mice, suggesting that the loss of periostin is able to delay disease progression. This is not without precedence because periostin is a known ECM cellular adhesion protein that, in other disease models, such as muscular dystrophy and myocardial infarction, has been shown to alter and even reduce the disease course. 18, 38 In agreement with those studies, we found that the absence of periostin significantly alters ECM remodeling within the atherosclerotic plaque. Specifically, we observed that the deletion of Postn resulted in decreased collagen maturation and cross linking and reduced the size of the fibrous cap, associated with increased gene expression of MMP3, MMP13, and procollagen-lysine, 2-oxoglutarate 5-dioxygenase-1. We found that periostin also affects the cellular composition of the plaque, marked by less inflammation and a pronounced phenotypic change of the inhabitant VSMC population toward a more synthetic phenotype. Finally, we observed that macrophages generated from WT bone marrow are more competent to migrate in response to inflammatory stimuli compared with those from Postn −/− mice. Although our data are unique in describing the role of periostin deletion in reducing the progression of atherosclerosis, our results are consistent with previous studies of both cardiac valve degeneration and arterial injury models where periostin-deficient mice were better protected from injury. 17, 22 In agreement with many models of acute and chronic injury, periostin was absent in the vessel wall at baseline but strongly re-expressed in the intima during atherosclerotic plaque formation. 18, 22, 38 In fact, periostin was previously detected in the intima of human-calcified atherosclerotic lesions, whereas it is absent in the vessel wall at baseline, indicating that periostin is re-expressed during vascular injury. 17, 23 Furthermore, a proteomic screen performed with human coronary arteries identified periostin as highly expressed in coronary atherosclerotic plaques. 23 In addition, a recent genomic study associated common variants of periostin with arterial lesions in young adults with premature development of atherosclerotic plaques. 39 Taken together, these data suggest a prominent role for periostin in the pathogenesis of atherosclerotic plaque formation and disease progression.
Previous work strongly suggests a direct interaction between periostin and other known ECM proteins, such as fibronectin, tenascin C, collagens I and V, heparin, and the MMPs. 4, 40 Periostin is known to be expressed in fibrous tissues, such as tendons, skin, and valves, where collagen is important to maintain biomechanical properties. Collagen I fibril maturation is critical to form a mature, cross-linked matrix. The loss of periostin disrupts this process resulting in defective collagen maturation indicating a prominent role of periostin in collagen fibrillogenesis. 4 In addition, previous studies in skin and during muscular dystrophy revealed that the maturity of collagen in the ECM is reduced in Postndeficient mice, resulting in altered wound healing marked by incomplete or delayed scar formation, which also holds true in the heart. 18, 19, 38, 41 Consistent with these data, we detected impaired collagen fibrillogenesis in ApoE −/− mice deficient for Postn as indicated by decreased collagen maturation in the plaques.
Given these observations, we suggest that the decreased plaque burden observed in the Postn −/− mice could be because of alterations in pathological ECM remodeling, where the lack of periostin directly alters the abundance, assembly, and biological properties of the collagen matrix in the plaque microenvironment. On the other hand, consistent with the pathology of human atherosclerotic lesions, we observed increased MMP3 expression in the aortas of ApoE −/− Postn −/− mice.
14 Interestingly, models of atherosclerosis that are genetically deficient for MMP3 have larger plaques with an unusual, defective ECM, associated with more collagen and fewer VSMCs. 13, 42 Thus, besides impaired collagen cross linking and maturation in the absence of periostin, one must consider that the immature collagen matrix noted in ApoE −/− Postn −/− plaques could be because of increased matrix degradation, which is supported by an increase in MMP3 activity. This is also supported by the increase in MMP13 and procollagenlysine, 2-oxoglutarate 5-dioxygenase-1 levels we observed in double-deficient mice compared with ApoE −/− mice. Studies have shown that MMP13 also contributes to collagen degradation and blocking MMP13 results in increased fibrous cap size. 31 Furthermore, procollagen-lysine, 2-oxoglutarate 5-dioxygenase-1 is involved in collagen cross linking and collagen maturation, suggesting that the double null mouse may be attempting to upregulate collagen cross-linking genes to compensate for this inherent defect in the Postn −/− mouse before disease onset. 32 Surprisingly, despite a decrease in mature collagen, the VSMCs in the aortas of the ApoE −/− Postn −/− mice do robustly switch from a contractile to synthetic phenotype, evident by increased proliferation, decreased α-SMA, decreased smooth muscle myosin heavy chain expression, increased osteopontin expression, and increased vimentin staining. 33, 34 This is consistent with a previous study that detected a decrease in the concentration of α-SMA positive cells at the site of injury in a Postn-deficient model of myocardial infarction. 19 Therefore, the decrease in the size of the fibrous caps observed in ApoE −/− Postn −/− mice is not because of changes in the characteristics of the VSMCs, as they still undergo a phenotypic switch but rather related to changes in the ECM microenvironment. The decrease in fibrous cap size may be potentiated by the inability of the VSMCs to migrate through the altered matrix. This is supported by previous work demonstrating that periostin directly affects cellular migration through known interactions with integrins. 43 Similar observations were made in other disease models where periostin was deleted, such as muscular dystrophy, where there was a decrease in inflammatory cells. 38 In addition, the plaques of ApoE −/− Postn −/− mice display a decrease in macrophage content. Macrophages that are deficient for periostin are unable to migrate in response to inflammatory stimuli, such as TGF-β. These data are supported by previous work showing that deficiency or inhibition of periostin prevents the development or progression of many allergic inflammatory diseases, including allergic dermatitis, asthma, and chronic rhinosinusitis. 44, 45 The presence of periostin in an inflammatory or injured environment seems to impart competency for macrophages to infiltrate and further affect disease.
Although the loss of Postn seems beneficial/protective with preserved vessel lumen and delayed disease progression, our model does not provide insights into the long-term ramifications of atherosclerosis, including plaque rupture, embolization, and subsequent tissue ischemia. Both human and animal studies have described plaques with a small fibrous cap as less stable and more prone to rupture, indicating that the atherosclerotic plaques in the ApoE −/− Postn −/− mice might be more disease predisposing. [46] [47] [48] [49] [50] However, the decrease in activated macrophages in the ApoE −/− Postn −/− mice may be beneficial, as inflammatory activity in human plaques is associated with a higher incidence of plaque rupture with subsequent thromboembolism leading to ischemic neurological and cardiovascular events. 51 It is well established that plaques in the atherosclerotic ApoE −/− mouse model are more resistant to rupture making it difficult to conclude whether the benefit of a decrease in plaque burden and inflammation outweighs the described benefit of a large stable fibrous cap. 52 The data presented here demonstrate that the loss of periostin in a mouse model of atherosclerosis decreases mature collagen production, inflammatory cell activation, and migration and alters VSMC behavior. Taken together, we can conclude that the loss of periostin delays atherosclerotic disease progression via alterations in the ECM and modification of the migratory potential of macrophages, a hallmark of atherosclerosis. Our results suggest periostin as a potential therapeutic target to slow the progression of disease associated with atherosclerosis. 
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